Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |